Vor Biopharma VOR
NASDAQ VOR
$18.06 -1.02 (-5.35%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vor Biopharma (VOR) Cash from Financing Activities (2020 - 2026)

Updated

Vor Biopharma's Cash from Financing Activities came in at -$106,000 for Q2 2026, compared with $175.07 million a year earlier.

Analysis

Vor Biopharma (VOR) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Vor Biopharma reported Cash from Financing Activities of $404.11 million, up 77.4% year-over-year; for FY2025, it was $503.81 million, up 843.6% from FY2024.

  • Cash from Financing Activities carries a five-year compound annual growth rate of 43.6% (FY2020 to FY2025).
  • Going back by year, Cash from Financing Activities was $53.39 million in FY2024, $2.94 million in FY2023 (-97.5%), $117.14 million in FY2022 (-49.7%) and $232.91 million in FY2021 (+182.2%).
  • The Q2 2026 figure represents the lowest quarterly Cash from Financing Activities since Q1 2025.
  • The fastest year-over-year change in Cash from Financing Activities over five years came in Q4 2021 (growth of 567.4%), and the weakest in Q4 2023 (a decline of 100.0%).
  • Business Quant data shows VOR's Cash from Financing Activities at $74.87 million (Q1 2026), $307.8 million (Q4 2025) and $21.55 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Vor Biopharma 1.04 Bn 1.04 Bn - -106,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -106,000.00
Mar 31, 2026 74.87 Mn
Dec 31, 2025 307.80 Mn
Sep 30, 2025 21.55 Mn
Jun 30, 2025 175.07 Mn
Mar 31, 2025 -606,000.00
Dec 31, 2024 53.29 Mn
Sep 30, 2024 41,000.00
Jun 30, 2024 -31,000.00
Mar 31, 2024 96,000.00
Dec 31, 2023 25,000.00
Sep 30, 2023 176,000.00
Jun 30, 2023 218,000.00
Mar 31, 2023 2.52 Mn
Dec 31, 2022 112.26 Mn
Sep 30, 2022 4.08 Mn
Jun 30, 2022 604,000.00
Mar 31, 2022 200,000.00
Dec 31, 2021 307,000.00
Sep 30, 2021 201,000.00
API Access

Vor Biopharma Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=VOR&period=max&api_key=YOUR_API_KEY